Jump to navigation
One-third of the sample who regularly used ecstasy had tested their illicit drugs in the last year.
In this publication, the authors examined the role of health practitioners (HP) in diversion and the circumstances surrounding their misconduct in Australia.
In this publication, the authors estimated the contribution of injection drug use to risk for HCV epidemics globally, regionally, and at country level.
The aim of this study was to review drug harms as they occur in Australia using the Multi-criteria Decision Analysis (MCDA) methodology adopted in earlier studies in other jurisdictions.
This study aims to describe the social, emotional and physical wellbeing of Aboriginal mothers in prison.
NCETA was commissioned by the National Centre for Clinical Research on Emerging Drugs (NCCRED) to develop a Workforce Development (WFD) strategy.
While EAPs have been utilised in various countries around the world, there has been limited research examining variations in the implementation and development of EAPs across countries.
Opioid overdose is a growing issue in Australia.
In this paper the authors comment on a recent publication by Neale et al.
The use of performance- and image-enhancing drugs (PIEDs) has been a topic of considerable research interest since the 1980s, with the vast majority of PIED consumers being men.
This study aimed to determine the prevalence and incidence of prescription opioid analgesic use in Australia and compare the characteristics of people with and without cancer initiating prescription opioid analgesics.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Thursday 29 October 2020